1. Home
  2. BWIN vs ZLAB Comparison

BWIN vs ZLAB Comparison

Compare BWIN & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Baldwin Insurance Group Inc.

BWIN

The Baldwin Insurance Group Inc.

HOLD

Current Price

$26.22

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$18.00

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWIN
ZLAB
Founded
2011
2013
Country
United States
China
Employees
5020
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
BWIN
ZLAB
Price
$26.22
$18.00
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$30.43
$49.60
AVG Volume (30 Days)
2.0M
968.1K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.46
EPS
N/A
N/A
Revenue
N/A
$460,156,000.00
Revenue This Year
$36.36
$9.75
Revenue Next Year
$10.82
$26.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.33
52 Week Low
$15.88
$15.96
52 Week High
$43.25
$41.20

Technical Indicators

Market Signals
Indicator
BWIN
ZLAB
Relative Strength Index (RSI) 69.92 45.85
Support Level $20.42 $16.78
Resistance Level $26.74 $19.41
Average True Range (ATR) 1.49 0.68
MACD 0.86 0.21
Stochastic Oscillator 98.08 55.79

Price Performance

Historical Comparison
BWIN
ZLAB

About BWIN The Baldwin Insurance Group Inc.

The Baldwin Insurance Group Inc is an insurance distribution company operating in the United States. The company provides commercial risk management, employee benefits, private risk management, and personal insurance solutions. It operates through three segments: Insurance Advisory Solutions, which focuses on commercial risk management and employee benefits; Underwriting, Capacity & Technology Solutions, which includes managing general agency operations, reinsurance brokerage, captive management, and technology-enabled insurance products; and Mainstreet Insurance Solutions, which offers personal, commercial, and life and health insurance products through community-based distribution channels.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: